INTERVENTIONAL NEUROLOGY MARKET ANALYSIS

Interventional Neurology Market, By Product Type (Embolic Protection Devices, Stents, Embolic Coils, Flow Diverter Devices, Stent Retrievers, Revascularization Device, Guide Sheaths, Neck Reconstruction Device, Catheters, and Others), By Application (Cerebral Aneurysm, Subarachnoid Hemorrhage, Ischemic Strokes, Extracranial & Intracranial Atherosclerosis, Head and Neck Tumors, and Others), By Technique (Angioplasty, Coil Embolization, Embolectomy, Stenting, Thrombectomy, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Dec 2024
Code : CMI56
Pages :156
Formats :
Excel and PDF
Industry : Medical Devices

The global interventional neurology market is expected to witness steady growth over the forecast period driven by the rising geriatric population and increasing prevalence of neurological disorders. The market is dominated by North America currently owing to the well-developed healthcare infrastructure and high accessibility to advanced treatment options in the region. Asia Pacific is likely to emerge as the fastest growing market owing to growing healthcare expenditure and improving clinical research landscape in China and India.
The market players are focusing on developing advanced technologies such as flow diversion devices, liquid embolic agents, and balloon occlusion devices to expand their product portfolios. Furthermore, the minimally invasive nature of interventional neurology procedures over conventional surgery is expected to boost the demand. However, high costs associated with these procedures and lack of skilled neurointerventionists in developing nations may hamper the market growth.
Rising neurological disease burden due to sedentary lifestyle and changing diets has compelled market players to invest heavily in R&D to develop innovative products. This has enabled improved treatment outcomes. The market is expected to get benefit from ongoing clinical trials evaluating efficacy and safety of various neurointerventional devices. Increasing preference for minimally invasive procedures is expected to create significant growth opportunities for existing as well as new market players in the long run.